Board Meeting8 Aug 2026, 07:20 pm
Johnson Pharmacare Board Meeting on Aug 13 to Approve Q1 FY27 Results
AI Summary
Johnson Pharmacare Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the Un-Audited (Standalone) Financial Results for the Quarter ended June 30, 2026. The company has also informed that the trading window for its securities will remain closed from July 1, 2026, until 48 hours after the declaration of these financial results. The meeting will take place at the company's registered office in Ahmedabad.
Key Highlights
- Board meeting scheduled for August 13, 2026.
- To approve Un-Audited (Standalone) Financial Results for Q1 FY27.
- Trading window closed from July 1, 2026, until results declaration.
- Meeting to be held at the registered office in Ahmedabad.
Price Impact
More from JOHNPHARMA